RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.140
0.00 (0.00%)
At close: Jan 31, 2025, 4:00 PM
1.145
+0.005 (0.44%)
After-hours: Jan 31, 2025, 4:00 PM EST
RAPT Therapeutics Employees
RAPT Therapeutics had 131 employees as of December 31, 2023. The number of employees increased by 34 or 35.05% compared to the previous year.
Employees
131
Change (1Y)
34
Growth (1Y)
35.05%
Revenue / Employee
n/a
Profits / Employee
-$820,550
Market Cap
153.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RAPT News
- 23 days ago - RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 26 days ago - RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - GlobeNewsWire
- 5 weeks ago - RAPT Therapeutics Announces $150 Million Private Placement - GlobeNewsWire
- 2 months ago - Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga
- 6 months ago - RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus - Seeking Alpha
- 9 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 9 months ago - RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity - Seeking Alpha
- 9 months ago - RAPT Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire